BePharBel Manufacturing SA

BePharBel Manufacturing SA

Pharmaceutical Manufacturing

HELPING CREATE A HEALTHIER WORLD THROUGH EXCELLENCE

About us

As CDMO (Contract and Development Manufacturing Organization), BePharBel Manufacturing contributes to improve the health of all by supplying our pharma partners: - a genuine end-to-end development and manufacturing solution - that facilitates and accelerates drugs availability for patients. Our main activities are: 1) CDMO BePharBel Manufacturing provides an integrated end-to-end solution for the development and manufacturing, under European GMP conditions, of drugs (small molecules and antibiotics) and medical devices. Our expertise field is the development of new formulations and drug formulations over more than 10 different sterile and non-sterile galenic forms (injectables, powder in vials, nasal sprays, creams, tablets…). Our CDMO covers all steps of development and production from manufacturing of clinical or commercial batches to analytical services, assistance supply with procurement of raw materials, packaging and serialisation. 2) Marketing Authorisation Holder of a portfolio of Rx, OTC and food supplements sold in Belgium and Luxembourg, mainly in Ophtalmology and Dermatology. 3) Development of innovative drug delivery systems such as our patented MMCR platform (MMCR: multi-layer micro-particle controlled release). This technology innovation enables the development of a controlled release syrup, which is a real breakthrough to help patients with swallowing impairments (paediatric and elderly).

Industry
Pharmaceutical Manufacturing
Company size
51-200 employees
Headquarters
Courcelles
Type
Privately Held
Founded
2013
Specialties
CDMO, Licensing, Services analytiques, Développement galénique, MMCR, Production EU-GMP, Médicaments, Dispositifs Médicaux, Compléments alimentaires, Produits humains, and Produits vétérinaires

Locations

Employees at BePharBel Manufacturing SA

Updates

  • 🌍 WHO Alert: Tuberculosis is on the Rise Globally With 8.2 million new tuberculosis cases diagnosed last year—the highest number in nearly 30 years—the WHO emphasizes the urgent health threat posed by this disease, now once again the world’s deadliest infection. In Belgium, a low-incidence country with approximately 1,000 new patients diagnosed each year, tuberculosis continues to affect vulnerable populations, most often in major cities. At BePharBel, we work daily to support this fight: we manufacture and distribute two of the four WHO-recommended frontline medications and provide diagnostic tests to organizations working directly with at-risk populations. We stand alongside belgian associations tackling this challenge head-on. https://lnkd.in/dRCqsbVY

    Tuberculosis resurges as top infectious disease killer

    Tuberculosis resurges as top infectious disease killer

    who.int

  • 🤝 Inspiring connections and new opportunities : a look back at BIO-Europe 2024 in Stockholm! Angel, our Head of Business Development, is back from BIO-Europe, where the energy was palpable and collaboration opportunities were abundant! This event allowed us to showcase our patented #MMCR platform and exchange ideas with experts in gastroenterology and paediatrics, as well as pharmaceutical distributors from around the world. The first application of our MMCR technology is the development of a gastro-resistant paediatric syrup for the treatment of #GERD. Thank you to everyone who took the time to connect with us and explore the potential of this innovation! These discussions are paving the way for exciting future collaborations. 📩 Want to learn more about our MMCR platform or discuss partnership opportunities? Contact us at ahu@bepharbel.com.

    • No alternative text description for this image
  • View organization page for BePharBel Manufacturing SA, graphic

    5,219 followers

    🌍 But where is Belgium? 🌍 Many of our non-European partners ask, “But where exactly is Belgium?” And nearly everyone wonders, “Where is Courcelles?” (We get it—our country is small! 😉) For those who still wonder : BePharBel Manufacturing is located in Courcelles - Belgium, just 60 km from Brussels, with excellent access to Brussels South Airport, Liège Freight Airport, and the Port of Antwerp. Here’s why partnering with a Belgian CDMO is a strategic advantage : ✔️ 🇧🇪 Fact 1 : Belgium may be known for its chocolate and beer, but we're also renowned for our pharma industry, including vaccines, sterile products and innovative drugs. ✔️ 🇧🇪 Fact 2 : Belgium leads Europe in pharmaceutical R&D spending per capita. ✔️ 🇧🇪 Fact 3 : Although Belgium represents only 2.6% of the EU population, the Belgian bio and traditional pharmaceutical industry accounts for 7.8% of jobs in the EU, placing Belgium in the 3rd position within the EU. ✔️ 🇧🇪 Fact 4 : In 2022, for the first time, more than 100 billion euros worth of medicines and vaccines were exported, confirming Belgium's unique position as an international hub for pharmaceuticals. ✔️ 🇧🇪 Bonus Fact : Belgians are friendly by nature, and even more so at BePharBel Manufacturing 😉 😊. Considering a CDMO partner in Europe? Belgium offers unparalleled advantages. With its robust infrastructure and vibrant pharma ecosystem, Belgium—and BePharBel—should be top of your list 😊. Did we miss any 🇧🇪 Facts? Comment below ! #Belgium #PharmaceuticalIndustry #CDMO #CMO

    • No alternative text description for this image
  • Get to know us better! 🌟 Are you curious about what it's like to partner with BePharBel Manufacturing? Here are the most frequently asked questions when we meet new partners for the first time, along with our answers! 🔹 What forms are you specialized in? We specialize in nasal sprays, syrup, sterile ophthalmic ointments, and injectable sterile powder in vials. These are the forms where we have the strongest experience and production capacity. But we have also facilities in dry forms. 🔹 What is your production capacity? Nowadays, our factory is manufacturing 40 different products every year. We have a robust production capacity that can meet a wide range of needs, tailored to the requirements of our partners with annual volume per product ranging from 200 000 sku up to 2 million. As it varies overtime due to current ongoing contracts, best is to contact us to get the latest information. 🔹 Where are you located? We are located in Courcelles, a small town near Charleroi, in the heart of Belgium and at the center of Europe. 🔹 Are you split across several sites? No. Bepharbel is an SME with all departments located on a single site for optimal integration, efficiency and speed to market. 🔹 What services do you provide? We specialize in the optimization of formulations for small molecules and drug formulation. We manage the entire drug production process from A to Z, including supply management, analytical services, stability studies, quality control, method validation, manufacturing, packaging, serialization, and release. 🔹 Do you handle formulation adjustments? Yes. We revise files and ensure compliance for the European market. 🔹 Do you produce clinical or commercial lots? We produce both. BePharBel Manufacturing has the capacity to meet your needs at clinical scale and to scale up your production as your product moves from clinical phases to commercialization. 🔹 Do you handle serialization? Yes, we do. 🔹 Will you be responsible for supply management? Yes, our objective is to manage the entire process from A to Z, including sourcing with our own supply chain team. 🔹 Are you Eu GMP compliant ? Yes. Our pharmaceutical products are developed and manufactured in accordance with the highest standards of quality and regulatory compliance. BePharBel Manufacturing adheres to the stringent regulations set by the European Medicines Agency (EMA). Since 2023, we comply to the new EU GMP Annex 1 for the manufacture of sterile medicinal products. Interested ? Let's plan a visit. Contact our team at dwy@bepharbel.com #PharmaceuticalIdustry #CDMO #CMO

    • No alternative text description for this image
  • Le week-end dernier, 12 de nos collaborateurs ont relevé le défi du DHL Ekiden, un marathon en relais. 🏃♂️🏃♀️ C'est une métaphore parfaite pour illustrer notre esprit d'équipe chez BePharBel ! Dans cette course, comme dans notre quotidien, le succès repose sur la force de l'équipe. Chaque membre joue un rôle essentiel, et chacun compte sur l'autre pour avancer. C'est exactement cet esprit d'entraide et de solidarité qui nous anime chez BePharBel. 💪🤝 Les défis ne manquent pas, les projets exigent souvent de l'endurance et de la détermination. Mais nous savons que nous pouvons toujours compter les uns sur les autres, au sein de nos équipes et entre elles. C'est cet état d'esprit qui nous pousse à aller plus loin, ensemble. Ça méritait bien un post, non ?

    • No alternative text description for this image
  • 🌟 What does the D of CDMO stand for at BePharbel Manufacturing? Traditionally, the "D" stands for Development, setting us apart from traditional pharma manufacturing third-party plants by providing comprehensive pre- and post-manufacturing services in the drug development chain. However, at BePharBel, the team has decided to give it its own special significance. For us, the "D" also stands for: ✔️ Dedication: Our team is motivated and always willing to go the extra mile. ✔️ Delivery: We ensure that your products reach the market efficiently and on time, meeting the highest standards. ✔️ Drive: We continuously enhance our processes through a culture of innovation and continuous learning. This makes our "D" synonymous with a commitment to excellence and a promise to deliver the best possible outcomes for our partners. Want to see how our "D" can make a difference in your project? Let's plan a visit or contact our team at dwy@bepharbel.com. #PharmaceuticalIdustry #CDMO #CMO

    • No alternative text description for this image

Similar pages